PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Google, Mountain View, CA, United States of America.\', \'Department of Biomedical Data Science, Stanford University, Stanford, CA, United States of America.\', \'Division of Neurocritical Care and Emergency Neurology, Yale School of Medicine, New Haven, CT, United States of America.\', \'Medical Wizdom, LLC, Brookline, MA, United States of America.\', \'Division of Neurocritical Care, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States of America.\', \'Harvard T.H. Chan School of Public Health, Boston, MA, United States of America. Electronic address: wei@hsph.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1551-7144(20)30223-810.1016/j.cct.2020.106145
?:hasPublicationType
?:journal
  • Contemporary clinical trials
is ?:pmid of
?:pmid
?:pmid
  • 32927092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.536
?:rankingScore_hIndex
  • 48
?:title
  • Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all